End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Jul. 12 | S&P 500 Rises Week-to-Week, Closes Near Highs Despite Mixed Inflation Data, Bank Earnings | MT |
Jul. 12 | Novartis Seeks Squeeze Out Approval at MorphoSys AGM | MT |
Sales 2024 * | 49.27B 44.05B | Sales 2025 * | 51.41B 45.96B | Capitalization | 228B 204B |
---|---|---|---|---|---|
Net income 2024 * | 10.73B 9.6B | Net income 2025 * | 12.02B 10.75B | EV / Sales 2024 * | 4.9 x |
Net Debt 2024 * | 13.22B 11.82B | Net Debt 2025 * | 11.6B 10.37B | EV / Sales 2025 * | 4.67 x |
P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
18.7
x | Employees | - |
Yield 2024 * |
3.31% | Yield 2025 * |
3.43% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+14.86% | 177B | |
+0.45% | 164B |